Literature DB >> 10546250

Medical technology assessment photic stimulation--standardization of screening methods.

D G Trenité1, C D Binnie, G F Harding, A Wilkins, T Covanis, O Eeg-Olofsson, L Goosens, O Henriksen, G Krämer, F Leyten, F H Da Silva, A M Da Silva, R Naquet, B Pedersen, S Ricci, G Rubboli, H Spekreijse, S Waltz.   

Abstract

RATIONALE: In many EEG laboratories in Europe, intermittent photic stimulation (IPS) is not performed routinely, and consequently, great variation exists in the type of photo stimulator used, the methodology employed, and the interpretation of the EEG curves, thus leading to different outcomes.
METHODOLOGY: It was decided to hold a consensus meeting with experts in the field of photic stimulation from various European countries. This meeting was held at the Stichting Epilepsie Instellingen Nederland, Heemstede, the Netherlands. The consensus reached was presented and discussed at the 9th European Congress of Clinical Neurophysiology in Ljubjana in June 1998.
RESULTS: Patients should be positioned at a distance of 30 cm from the photic stimulator (nasion to lamp) with dim surrounding lights, just enough to see the patient. Flashes should be delivered in separate trains of 10 s for each frequency, with intervals of 7 s minimum. First stimulation occurs with eyes open followed after 5 s by eye closure, while starting at 1 Hz progressing to 20 Hz, unless generalised epileptiform discharges are evoked at a lower frequency. Then, frequencies should start at 60 Hz decreasing to 25 Hz. The following frequencies should be used: 1, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 60, 50, 40, 30 and 25 Hz. The total duration is a maximum of 6 min (patients without a reaction to IPS). In interpreting the evoked responses, a clear distinction should be made between epileptiform responses confined to the occipital area (OSW), starting occipitally and spreading to frontal regions (OGSW), or generalised from the start (GSW). Other responses include generalised spikes (OR).
CONCLUSION: This standard is safe, relatively quick, simple and reliable. Comparison of data within patients and between patients of various laboratories will also be possible. This will improve the quality of the care of the individual patient and make collaborative research possible.

Entities:  

Mesh:

Year:  1999        PMID: 10546250     DOI: 10.1016/s0987-7053(99)90045-x

Source DB:  PubMed          Journal:  Neurophysiol Clin        ISSN: 0987-7053            Impact factor:   3.734


  1 in total

1.  Safety Aspects, Tolerability and Modeling of Retinofugal Alternating Current Stimulation.

Authors:  Linus Haberbosch; Abhishek Datta; Chris Thomas; Andreas Jooß; Arvid Köhn; Maria Rönnefarth; Michael Scholz; Stephan A Brandt; Sein Schmidt
Journal:  Front Neurosci       Date:  2019-08-07       Impact factor: 4.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.